Kembuka: Benefits, Evidence & Safety
TL;DR
Kembuka is the Sanskrit name for Costus speciosus (crepe ginger), whose rhizome is used in Ayurveda for fever, worms, and urinary and liver complaints. Laboratory and animal studies report blood-sugar-lowering, anti-inflammatory, liver-protective, and hormone-like effects. No human clinical trials exist, and animal work flags antifertility and uterus-stimulating effects: so human benefits and safety are unproven.
(55 words. Sources: PMC pharmacognostic study; Springer BNRC review; phytojournal Kebuka review.)
What it is
Kembuka is the Sanskrit name for Costus speciosus Koen. (family Costaceae; also published as Hellenia speciosa and Cheilocostus speciosus): "commonly known as keukand in Hindi; Kembuka in Sanskrit" (PMC pharmacognostic study). It is a tall, erect, succulent perennial herb (up to about 2.7 m) growing from a horizontal rhizome, found across tropical India. The rhizome is the main part used in traditional medicine; the leaves and stem are also employed.
Traditional use
In Ayurveda, kembuka is described as bitter, astringent, acrid, and cooling, with aphrodisiac, purgative, anthelmintic, depurative, and febrifuge properties (PMC study). The rhizomes are traditionally used for pneumonia, rheumatism, dropsy, urinary diseases, and jaundice; the leaves for mental disorders. Bruised leaves are applied in fever; and a stem decoction is used for fever and dysentery (same study). Classical formulations containing kebuka include Kulathādi Ghritha (for chronic fever), Khadirādi Vati (for mouth diseases), and Shatāvaryādi Uttara Basti (for urinary obstruction) (phytojournal review). These are traditional claims, not clinical proof.
What modern research says
Blood sugar
Reviews of Costus speciosus report antihyperglycemic and antidiabetic activity in diabetic animals: the steroidal saponin diosgenin is described as lowering blood glucose by inhibiting gluconeogenesis and the carbohydrate-digesting enzymes α-glucosidase and α-amylase while promoting glycogenesis, and the sesquiterpene lactone costunolide as stimulating pancreatic β cells to release insulin (Springer review). These mechanisms come from animal and cell work; no human trial has tested kembuka for diabetes.
Inflammation and oxidative stress
The same review attributes anti-inflammatory and antioxidant effects to constituents including stigmasterol, β-sitosterol, santamarine, and arbusculin A (Springer review). A pharmacognostic study also lists published reports of antioxidant, antibacterial, and antifungal activity (PMC). All of this is preclinical: test tubes and animals, not people.
Liver protection
Animal studies report hepatoprotective effects of C. speciosus extracts (phytojournal review). This is preliminary and does not establish a liver benefit in humans.
Cancer cells in the lab
Costunolide and its derivatives reduced the viability of cancer cells in laboratory studies by increasing caspase-3 activity and regulating cell-death pathways, and a 2025 review noted cytotoxic effects against breast, ovarian, and uterine cancer cell lines with induction of apoptosis (Springer review; Al-Dhuayan et al., 2025). Cell studies are the earliest stage of research: they are not evidence of a cancer treatment.
What the evidence does not support (yet)
No human clinical trials of kembuka were found for any condition: not diabetes, inflammation, liver disease, or cancer. Traditional claims for pneumonia, dropsy, and mental disorders have no modern clinical backing.
Safety & contraindications
No human safety trials of kembuka exist. In animals, ethanolic extracts showed no significant adverse effects at doses up to 1100 mg/kg/day (phytojournal review). Two findings argue for caution anyway: the plant has a uterine-contracting (garbhashaya sankochaka) property, so it should be avoided in pregnancy, and its diosgenin content shows estrogenic and antifertility effects in animals (same review). Couples trying to conceive should avoid it, and anyone on medication should talk to a clinician first: safety data is limited.
FAQs
What is kembuka?
Kembuka is the Sanskrit name for Costus speciosus (family Costaceae), known in English as crepe ginger and in Hindi as keukand: "commonly known as keukand in Hindi; Kembuka in Sanskrit" (PMC pharmacognostic study). It is a tall, erect perennial herb growing from a horizontal rhizome, and the rhizome is the main part used in Ayurveda.
Does kembuka help with diabetes?
Only in animals so far. Reviews report that Costus speciosus extracts lower blood sugar in diabetic animals, with diosgenin acting on glucose-metabolizing enzymes and costunolide stimulating insulin release from pancreatic β cells (Springer review). No human trial has tested kembuka for diabetes, so it is not an evidence-based diabetes treatment.
Is kembuka safe?
There are no human safety trials. In animals, ethanolic extracts showed no significant adverse effects at doses up to 1100 mg/kg/day (phytojournal review), but animal tolerance does not guarantee human safety. Because the plant also shows uterine-stimulating and antifertility effects in animals, it should not be assumed safe: talk to a clinician first.
Can pregnant women use kembuka?
No: not based on current evidence. A review of Costus speciosus notes a uterine-contracting (garbhashaya sankochaka) property and recommends against use in pregnancy (phytojournal review). Diosgenin in the plant also shows estrogenic and antifertility effects in animals. Pregnant women and couples trying to conceive should avoid it.
Is kembuka the same as kushtha (costus root)?
No. This is a common confusion. Kembuka is Costus speciosus (crepe ginger, family Costaceae). The "costus" or "kushtha" of many Western references is Saussurea costus (family Asteraceae), a completely different Himalayan plant. They are not interchangeable: check product labels for the Latin name before buying.
What part of the kembuka plant is used?
The rhizome is the main medicinal part in Ayurveda, used for urinary disorders, jaundice, rheumatism, and fevers. The leaves are used for mental disorders and applied bruised in fever, and a stem decoction is used for fever and dysentery (PMC study). Most pharmacological research has tested rhizome extracts.
Sources
- Srivastava et al. "Pharmacognostical study and establishment of quality parameters of aerial parts of Costus speciosus" (PMC) — PMC · PMC3994359
- "Phytochemical competence and pharmacological perspectives of an endangered boon — Costus speciosus (Koen.) Sm.: a comprehensive review" (Bulletin of the National Research Centre, Springer) — link.springer.com
- Al-Dhuayan et al. "Exploring the anticancer potential of Costus speciosus: a comprehensive review" (Brazilian Journal of Biology, 2025; PubMed) — PubMed · PMID 40435094
- "A comprehensive review on Kebuka [Costus speciosus (J. Konig) Sm.] in Ayurveda" (Phytojournal) — phytojournal.com
- "Targeting prostate cancer cell proliferation, stemness and metastatic potential using Costus speciosus derived phytochemicals" (PMC; traditional-use background) — PMC · PMC6511805
Related herbs
Disclaimer
This article is for educational purposes only and is not medical advice. Herbal products can interact with medications and are not suitable for everyone. Talk to a qualified healthcare practitioner before use — especially if you are pregnant, breastfeeding, managing a medical condition, or taking prescription medicines.